Significance of consecutive international normalized ratio (INR) outcomes using statistical control rules in long-term anticoaguated patients. Optimitization of laboratory monitoring and interpretation of borderline measurements

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 3, 2004, Pages 294-299

  Introcaso, Giovanni ^a   Gesu, Goampietro ^a  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

Author keywords

Borderline measurements; International normalized ratio (INR) variability; Oral anticoagulant therapy; Statistics; Therapeutic control chart

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT;

ALARM MONITORING; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CALCULATION; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL PRACTICE; CONSTANTS AND COEFFICIENTS; CONTROLLED STUDY; DISEASE SEVERITY; DOSE CALCULATION; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL STANDARD UNIT; LABORATORY TEST; LONG TERM CARE; MEDICAL RECORD; METHODOLOGY; OUTCOMES RESEARCH; PATIENT MONITORING; PATIENT SELECTION; PRIORITY JOURNAL; PROBABILITY; PROCESS OPTIMIZATION; REFERENCE VALUE; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; THROMBOEMBOLISM;

ALGORITHMS; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; DRUG MONITORING; HUMANS; INTERNATIONAL NORMALIZED RATIO; LABORATORIES, HOSPITAL; NORMAL DISTRIBUTION; PROBABILITY; PROTHROMBIN TIME; RETROSPECTIVE STUDIES; STATISTICAL DISTRIBUTIONS;

EID: 1842737108     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.053     Document Type: Article

References (16)

1. Hirsh J, Dalen J, Deykin D, Poller L, Bussey H. Oral anticoagulants, mechanism of action, clinical effectiveness and optimal therapeutic range. Chest 1995;108:231S-242S.
2. Introcaso G, Cuboni A, Ratto A, Foieni F. Mathematical derivative applied to international normalised ratio and analytical variations in oral anticoagulant therapy control. Haemostasis 2000;30:281-9.
3. Houbouyan Lucie L, Goguel AF. Long-term French experience in INR standardization by a procedure using plasma calibrants. Am J Clin Pathol 1997;108:83-9.
4. Kitchen S, Jennings I, Woods TA, Preston FE. Local calibration of international normalised ratio improves between laboratory agreement: results from the UK national external quality assessment scheme. Thromb Haemost 1999;81:60-5.
5. Chantarangkul V, Tripodi A, Cesana BM, Mannucci PM. Calibration of local system with lyophilized calibrant plasmas improves the interlaboratory variability of the INR in the Italian external quality assessment scheme. Thromb Haemost 1999;82:1621-6.
6. Lassen JF, Kjeldsen J, Antonsen S, Petersen PH, Brandslund I. Interpretation of serial measurements of international normalised ratio for prothrombin times in monitoring oral anticoagulant therapy. Clin Chem 1995;41:1171-6.
7. van den Besselaar AMHP, Poller L, Tripodi A, on behalf of the WHO/ISTH Consultation Group. Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy. World Health Organization, Tech Rep Ser 1999;889:64-93.
8. Kjeldsen J, Lassen JF, Petersen PH, Brandslund I. Biological variation of international normalised ratio for prothrombin times, and consequences in oral anticoagulant therapy: computer simulation of serial measurements with goal-setting for analytical quality. Clin Chem 1997;43:2175-82.
9. Introcaso G, Foieni F, Ratto A, Cuboni A. Evaluation of critical differences of international normalized ratio in oral anticoagulant control [abstract]. Thromb Haemost 1999; (Suppl): 1267.
10. Matthews DE, Farewell VT. Using and understanding medical statistics, 3rd ed. Karger 1996:84-97.
11. Rosendaal FR, Cannegieter SC, van der Meer FJM, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993;69:236-9.
12. Lassen JF, Brandslund I, Antonsen S. International normalized ratio for prothrombin times in patients taking oral anticoagulants: critical difference and probability of significant change in consecutive measurements. Clin Chem 1995;41/:444-7.
13. Odén A, Fahlén M. Oral anticoagulation and risk of death: a medical record linkage study. Br Med J 2002;325:1073-5.
14. Manotti C, Moia M, Palareti G, Pengo V, Ria L, Dettori AG. Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, ramdomized, multicenter trial of APROAT (Automated Program for Oral Anticoagulant Treatment). Haematologica 2001;86:1060-70.
15. Poller L, Shiach CR, MacCallum PK, Johansen AM, Munster AM, Magalhaes A, et al. Multicentre randomised study of computerised anticoagulant dosage. European concerted Action on Anticoagulation. Lancet 1998; 352: 1505-1509.
16. Poller L, Jespersen J. European concerted action on anticoagulation (ECAA) - clinical benefit of computerised warfarin dosage [abstract]. Thromb Haemost 2001;(Suppl):P768.